Funding rounds/Agomab Therapeutics

Agomab Therapeutics

Series D+

Ghent, BelgiumFounded 2017Oct 2024

Amount raised

€83M

€83,115,463

Native amount

90,000,000 USD

Stage

Series D+

series d

Investors

Provenance & confidence

High confidence

Amount

90,000,000 USD

ECB-at-date → €83M · rate 1.0825 on 2024-10-25

High confidence

Source

elreferente.es · established

High confidence

Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.

Date

Oct 2024

Round type

series d

Amount (EUR)

€83M

same company